Generation of an Oocyte-Specific Cas9 Transgenic Mouse for Genome Editing.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 27119535.
- Also identified by DOI 10.1371/journal.pone.0154364 and PMC identifier 4847922.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The CRISPR/Cas9 system has been developed as an easy-handle and multiplexable approach for engineering eukaryotic genomes by zygote microinjection of Cas9 and sgRNA, while preparing Cas9 for microinjection is laborious and introducing inconsistency into the experiment. Here, we describe a modified strategy for gene targeting through using oocyte-specific Cas9 transgenic mouse. With this mouse line, we successfully achieve precise gene targeting by injection of sgRNAs only into one-cell-stage embryos. Through comprehensive analysis, we also show allele complexity and off-target mutagenesis induced by this strategy is obviously lower than Cas9 mRNA/sgRNA injection. Thus, injection of sgRNAs into oocyte-specific Cas9 transgenic mouse embryo provides a convenient, efficient and reliable approach for mouse genome editing.
Medical subject headings
- CRISPR-Cas Systems
- Gene Targeting
- Mice, Transgenic
- Oocytes